News
18h
Zacks Investment Research on MSNKALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?Shares of KalVista Pharmaceuticals KALV have soared 36% in the past week, all thanks to the FDA’s approval of its lead ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
For the World Day for Grandparents and the Elderly which is set to be celebrated on July 27, Pope Leo XIV issued a message of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results